Correlation of Interleukin-17-Producing Effector Memory T Cells and CD4⁺CD25⁺Foxp3 Regulatory T Cells with the Phosphate Levels in Chronic Hemodialysis Patients

Table 1

Baseline clinical characteristics of subjects (mean ± SD) in the diabetes and nondiabetes groups.

	Total	Diabetes group	Nondiabetes group
Patients (𝑛)	105	52	53
Age (years)	65.72 ± 13.7	66.35 ± 12.6	65.11 ± 14.8
Sex (M/F)	55/50	29/23	26/27
HBsAg (+/−)	8/97	4/48	4/49
Anti-HCV (+/−)	14/91	3/49	11/42*
Cause of end-stage renal disease	ADPKD: 3, CGN: 13, diabetes: 44, heart failure: 1, HTN: 36, obstructive nephropathy: 4, and SLE: 3	CGN: 1, diabetes: 44, heart failure: 1, and HTN: 6	ADPKD: 3, CGN: 12, HTN: 30, heart failure: 1, obstructive nephropathy: 4, and SLE: 3
Dialysis vintage (months)	55.3 ± 58.6	46.21 ± 37.5	64.25 ± 73.1

 *𝑃<0.05 versus the diabetes group.
CGN: chronic glomerulonephritis; HTN: hypertension; ADPKD: autosomal dominant polycystic disease; SLE: systemic lupus nephritis.